This proposal is a resubmission of the University of Arizona Cancer Center?s (UACC) Cancer Prevention and Control R25T postdoctoral training program re-competition. This program was first funded by the National Cancer Institute (NCI) in 1998 as a R25T and currently continues under that mechanism (2R25CA078447). Our R25T program is currently in a no cost extension year and has supported 9 successful postdoctoral fellows over the current grant cycle (2010 ? 2015), 44% of whom are from underserved populations. This T32 proposal requests 4 postdoctoral positions per year for two-year training periods with the goal to train a maximum of 10 postdoctoral trainees over five years. Upon program completion, T32 fellows will be prepared to proceed to successful and productive independent cancer health disparity research careers that contribute to decreases in cancer morbidity and mortality among underserved populations. This will be achieved through two designated foci: 1) recruit qualified trainees committed to cancer prevention work in underserved populations, including researchers from underserved communities and those with an interest in cancer health disparities science; and 2) train individuals in cancer prevention and control and health disparities science to reduce health disparities. During this training program, fellows will be required to 1) engage in a primary research project along with required coursework, including a health disparities training curriculum; 2) attend and lecture in the weekly UACC Cancer Prevention and Control seminar series; 3) submit their work for presentation and publication in peer-reviewed journals; 4) attend scientific and career development meetings; and 5) develop a grant proposal for research funding. This proposed Cancer Prevention and Control Health Disparities Training Program aligns with the University of Arizona?s strategic plan and addresses the needs of our State?s unique population (25.5% Hispanic, 4.1% African-American, and 5.8% Native American residents, as compared to national averages of 15.8% Hispanic/Latino, 12.6% African-American, and 0.7% Native American (US Census Bureau)). This distinctive geographic location along with our strong community ties, university partnerships, CPC postdoctoral training history, and university infrastructure and resources uniquely position us to train the next generation of CPC researchers focused on reducing health disparities and working with underserved communities.

Public Health Relevance

Cancer health disparities are frequently seen in people from low-socioeconomic groups, certain racial/ethnic populations, and those who live in geographically isolated areas. The overall goal of this Cancer Prevention and Control Health Disparities T32 Training Program is to create a diverse workforce of cancer prevention and control scientists working in underserved populations to reduce cancer health disparities. This multi-faceted training experience includes the conduct of a specialized research project, didactic instruction, seminars, and individual multidisciplinary mentoring teams of highly experienced and peer reviewed research funded faculty investigators.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
2T32CA078447-16A1
Application #
9208596
Study Section
Subcommittee F - Institutional Training and Education (NCI-F)
Program Officer
Lim, Susan E
Project Start
2016-09-15
Project End
2021-08-31
Budget Start
2016-09-15
Budget End
2017-08-31
Support Year
16
Fiscal Year
2016
Total Cost
$237,281
Indirect Cost
$18,137
Name
University of Arizona
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
806345617
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Centuori, Sara M; Gomes, Cecil J; Kim, Samuel S et al. (2018) Double-negative (CD27-IgD-) B cells are expanded in NSCLC and inversely correlate with affinity-matured B cell populations. J Transl Med 16:30
Jeter, Joanne M; Curiel-Lewandrowski, Clara; Stratton, Steven P et al. (2016) Phase IIB Randomized Study of Topical Difluoromethylornithine and Topical Diclofenac on Sun-Damaged Skin of the Forearm. Cancer Prev Res (Phila) 9:128-34
Czamanski-Cohen, J; Weihs, K L (2016) The Bodymind Model: A platform for studying the mechanisms of change induced by art therapy. Arts Psychother 51:63-71
Bermudez, Yira; Benavente, Claudia A; Meyer, Ralph G et al. (2011) Nicotinic acid receptor abnormalities in human skin cancer: implications for a role in epidermal differentiation. PLoS One 6:e20487